Also trades as: KIMS.BO (BSE) · $vol 1M
KIMS.NS NSE
Krishna Institute of Medical Sciences Limited
1W: -8.0%
1M: -2.9%
3M: -13.4%
YTD: +13.3%
1Y: +0.7%
3Y: +84.2%
5Y: +194.6%
₹738.35 ($7.67)
+2.10 (+0.29%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$77.6B
+35.3% ▲
5Y CAGR: +40.1%
Total Liabilities
$52.0B
+56.8% ▲
5Y CAGR: +56.2%
Shareholders Equity
$22.5B
+5.1% ▲
5Y CAGR: +21.1%
Cash & Investments
$898M
-11.7% ▼
5Y CAGR: -20.6%
Total Debt
$42.5B
+66.3% ▲
5Y CAGR: +68.2%
Net Debt
$41.8B
+68.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $256M | $616M | $469M | $797M | $747M |
| Short-Term Investments | $1.6B | $726M | $851M | $220M | $151M |
| Cash & ST Investments | $1.9B | $1.3B | $1.3B | $1.0B | $898M |
| Net Receivables | $1.4B | $2.7B | $3.2B | $4.0B | $6.3B |
| Inventory | $364M | $429M | $494M | $640M | $969M |
| Other Current Assets | $210M | $264M | $379M | $1.4B | $1.2B |
| Total Current Assets | $3.9B | $4.8B | $5.5B | $7.0B | $9.4B |
| Property, Plant & Equip. | $9.1B | $18.6B | $26.6B | $41.6B | $59.2B |
| Goodwill & Intangibles | $1.2B | $3.9B | $3.7B | $4.1B | $4.0B |
| Long-Term Investments | $3.3B | -$160M | $1.0B | $771M | $1.8B |
| Other Non-Current Assets | $1.5B | $2.0B | $1.3B | $4.0B | $2.0B |
| Total Non-Current Assets | $15.1B | $24.6B | $33.0B | $50.4B | $68.2B |
| Total Assets | $19.1B | $29.4B | $38.5B | $57.4B | $77.6B |
| — Liabilities — | |||||
| Accounts Payable | $1.3B | $1.7B | $2.0B | $2.7B | $3.2B |
| Short-Term Debt | $234M | $358M | $1.2B | $2.5B | $6.2B |
| Deferred Revenue | $135M | $170M | $242M | $0 | $0 |
| Other Current Liabilities | $53M | $164M | $413M | $2.7B | $3.0B |
| Total Current Liabilities | $2.2B | $3.0B | $4.5B | $8.4B | $12.4B |
| Long-Term Debt | $1.4B | $5.0B | $9.3B | $16.5B | $26.7B |
| Other Non-Current Liab. | $174M | $240M | $339M | $1.5B | $2.6B |
| Total Non-Current Liabilities | $2.8B | $7.1B | $13.1B | $24.8B | $39.6B |
| Total Liabilities | $5.0B | $10.0B | $17.6B | $33.2B | $52.0B |
| — Equity — | |||||
| Common Stock | $800M | $800M | $800M | $800M | $800M |
| Retained Earnings | $2.7B | $5.4B | $7.2B | $10.4B | $0 |
| Accumulated OCI | $58M | $172M | $0 | -$114M | $0 |
| Total Stockholders Equity | $13.9B | $16.7B | $18.3B | $21.4B | $22.5B |
| Total Liabilities & Equity | $19.1B | $29.4B | $38.5B | $57.4B | $77.6B |
| — Key Metrics — | |||||
| Total Debt | $2.6B | $6.8B | $13.6B | $25.6B | $42.5B |
| Net Debt | $2.3B | $6.2B | $13.1B | $24.8B | $41.8B |
| Total Investments | $5.0B | $567M | $1.9B | $991M | $1.9B |